Received Sep 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 9C295 | IM / RL |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 2 | Y018677 | IM / LA |
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | 2 | Z0033633 | IM / LA |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 2 | Z007575 | PO / MO |
On the same day as vaccination the patient began to have red rash on face and fatigue. By 8/10, two days later, he had significant facial and eye swelling and presented to ER seen by Dr, MD. Pt had no difficulty breathing, no diarrhea, no vomiting, no fever, no loss of consciousness. He was given dexamethasone and Benadryl in the ER. By 8/12 the symptoms had fully resolved except some residual peeling from face. Follow up with PCP in clinic on 8/14. Fully resolved.
none
constipation
none
none
Respiratory Virus Panel PCR was negative